Distribution of retroviral vectors and vector producer cells using two routes of administration in rats
- 1 August 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (8) , 1389-1396
- https://doi.org/10.1038/sj.gt.3300983
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 11 references indexed in Scilit:
- Molecular Evaluation of Biopsy and Autopsy Specimens from Patients Receiving in Vivo Retroviral Gene TherapyHuman Gene Therapy, 1999
- Biosafety Monitoring of Patients Receiving Intracerebral Injections of Murine Retroviral Vector Producer CellsHuman Gene Therapy, 1998
- Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cellsNature Medicine, 1997
- The α-Galactosyl Epitope: A Sugar Coating That Makes Viruses and Cells UnpalatableCell, 1996
- A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.The Journal of Experimental Medicine, 1995
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain. A light and electron microscopical immunocytochemical studyJournal of Neuroimmunology, 1991
- Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell lineJournal of Neuroscience Research, 1990
- Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.Molecular and Cellular Biology, 1986